Market closed
Pulse Biosciences/$PLSE
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Pulse Biosciences
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Ticker
$PLSE
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
56
Website
PLSE Metrics
BasicAdvanced
$1.2B
-
-$0.83
1.74
-
Price and volume
Market cap
$1.2B
Beta
1.74
52-week high
$22.69
52-week low
$6.60
Average daily volume
148K
Financial strength
Current ratio
11.929
Quick ratio
11.724
Long term debt to equity
9.066
Total debt to equity
10.574
Interest coverage (TTM)
-44.12%
Management effectiveness
Return on assets (TTM)
-38.15%
Return on equity (TTM)
-70.28%
Valuation
Price to book
15.35
Price to tangible book (TTM)
16.2
Price to free cash flow (TTM)
-32.102
Growth
Earnings per share change (TTM)
-5.61%
3-year earnings per share growth (CAGR)
-28.80%
What the Analysts think about PLSE
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Pulse Biosciences stock.
PLSE Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PLSE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PLSE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Pulse Biosciences stock?
Pulse Biosciences (PLSE) has a market cap of $1.2B as of January 30, 2025.
What is the P/E ratio for Pulse Biosciences stock?
The price to earnings (P/E) ratio for Pulse Biosciences (PLSE) stock is 0 as of January 30, 2025.
Does Pulse Biosciences stock pay dividends?
No, Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders as of January 30, 2025.
When is the next Pulse Biosciences dividend payment date?
Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders.
What is the beta indicator for Pulse Biosciences?
Pulse Biosciences (PLSE) has a beta rating of 1.74. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.